• Marilù Bartiromo, Beatrice Borchi, Annarita Botta, Alfredo Bagalà, Gianmarco Lugli, Marta Tilli, Annalisa Cavallo, Brunilda Xhaferi, Roberta Cutruzzulà, Augusto Vaglio, Silvia Bresci, Aida Larti, Alessandro Bartoloni, and Calogero Cirami.
• Nephrology Unit, Careggi University Hospital, Florence, Italy.
• Transpl Infect Dis. 2020 Aug 1; 22 (4): e13286.

AbstractDuring the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney-transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough, and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after 2 days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy.© 2020 Wiley Periodicals LLC.

85 keywords...

hide…